SUBSCRIBE
SUBSCRIBE
News   Business

Enzo Biochem Appoints Gary C. Cupit, Former Novartis Pharmaceuticals Corporation Executive, President Of Enzo Biochem Therapeutics Unit

October 16, 2006 | 
1 min read

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) today announced the appointment of Gary C. Cupit, PharmD, to the newly created position of President of Enzo Therapeutics, Inc.

People
Novartis
MORE ON THIS TOPIC
Find understanding between people. Reach your opponent. Building a bridge of understanding and reasoning. Discover common ground. Pave way for cooperation or peaceful disagreement. Resolving conflict
Mergers & acquisitions
Bluebird’s Second Suitor, Ayrmid, Fails To Produce an Offer
April 16, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Art 3d banner collage of business people dollar roll cooperation success payment capital profit transaction money corruption.
Rare diseases
Glycomine Gets $115M Series C for Rare Disease, Aims for Phase II Launch Mid-Year
April 16, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Podcast
Tariff Turmoil, FDA’s Future, Pfizer’s Obesity Setback and CEO Salaries Revealed
April 16, 2025
 · 
1 min read
 · 
Heather McKenzie
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives
April 15, 2025
 · 
179 min read
 · 
BioSpace Editorial Staff